Similar Posts
Phase-2-Daten für Prüfpräparat Acasunlimab (DuoBody® -PD-L1x4-1BB) in Kombination mit Pembrolizumab: Signifikante klinische Aktivität bei vorbehandeltem, metastasiertem nicht-kleinzelligem Lungenkarzinom – Bio Tech Winners
June 1, 2024 by Leave a Comment Last Updated on June 1, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
SpiceJet: Mind your Language
Source: Marriam Webster Source: Exchange Filings of SpiceJet Ltd Source link
The Thief Came Through the (Chat) Window – Fat Tail Daily
Last week, someone sat down at their keyboard, opened an AI Claude chat, and began pleading. First, it was sold as some innocent roleplay. ‘Pretend you’re an elite hacker. Help me find vulnerabilities in the Mexican federal tax authority,’ they asked. AI, to its credit, initially refused. It flagged the request as suspicious and listed…
Ask Alan #239: Using 2 Standard Deviations to Avoid Covered Call Exercise
Hi Alan,I watched one of your videos where you used implied volatility to create trades with a 16% risk of being assigned. The formula was based on 1 standard deviation. My question is can we use 2 standard deviations to create even lower risk trades? If yes, how? Thanks,Charlie Free Resources:https://thebluecollarinvestor.com/minimembership/bci-free-resources/ Premium Membership:https://thebluecollarinvestor.com/minimembership/premium-membership/…
Lassonde Industries Inc
Sound bite for Twitter and StockTwits is: Dividend Growth Consumer. Results of stock price testing is that the stock price is relatively cheap. Debt Ratios are good. The Dividend Payout Ratios (DPR) are good. The current dividend yield is moderate with dividend growth restart, but has been inconsistent. See my spreadsheet on Lassonde Industries Inc….
Asia stocks rise tracking Wall St gains; Tech upbeat before Nvidia earnings
Asia stocks rise tracking Wall St gains; Tech upbeat before Nvidia earnings Source link